High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease
- PMID: 20956091
- PMCID: PMC3061829
- DOI: 10.1016/j.clim.2010.08.003
High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease
Abstract
Chronic granulomatous disease (CGD) and inflammatory bowel disease (IBD) have overlapping gastrointestinal manifestations. Serum antibodies to intestinal microbial antigens in IBD are thought to reflect a loss of tolerance in the setting of genetically encoded innate immune defects. CGD subjects studied here, with or without colitis, had considerably higher levels of ASCA IgA, ASCA IgG, anti-OmpC, anti-I2, and anti-CBir1, but absent to low pANCA, compared to IBD-predictive cutoffs. Higher antibody levels were not associated with a history of colitis. Except for higher ASCA IgG in subjects <18 years, antibody levels were not age-dependent. In comparison, 7 HIES subjects expressed negative to low antibody levels to all of these antigens; none had colitis. Our results suggest that markedly elevated levels of antimicrobial antibodies in CGD do not correlate with a history of colitis but may reflect a specific defect in innate immunity in the face of chronic antigenic stimulation.
Copyright © 2010 Elsevier Inc. All rights reserved.
Conflict of interest statement
C.C.R. has received research support from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, has served on the medical advisory boards of Talecris Corporation and Baxter Therapeutics, and has received a research grant from Baxter Therapeutics.
S.T. is a founder and on the Board of Directors of Prometheus RxDx, Inc.
J.E.Y., S.S.R., G.U., C.L., H.L.M., S.M.H., W.Q., N.H., and L.M. have declared that they have no conflict of interest.
Figures



Similar articles
-
Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.Am J Gastroenterol. 2004 Nov;99(11):2235-41. doi: 10.1111/j.1572-0241.2004.40369.x. Am J Gastroenterol. 2004. PMID: 15555007
-
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.Gastroenterology. 2020 Jul;159(1):96-104. doi: 10.1053/j.gastro.2020.03.007. Epub 2020 Mar 9. Gastroenterology. 2020. PMID: 32165208
-
Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study.Arthritis Res Ther. 2013 Oct 26;15(5):R166. doi: 10.1186/ar4350. Arthritis Res Ther. 2013. PMID: 24286190 Free PMC article.
-
[Relevance of serologic studies in inflammatory bowel diseases].Orv Hetil. 2007 May 13;148(19):887-96. doi: 10.1556/OH.2007.28064. Orv Hetil. 2007. PMID: 17478404 Review. Hungarian.
-
Advances in clinical laboratory tests for inflammatory bowel disease.Clin Chim Acta. 2003 Sep;335(1-2):9-20. doi: 10.1016/s0009-8981(03)00286-9. Clin Chim Acta. 2003. PMID: 12927679 Review.
Cited by
-
Gastrointestinal Manifestations and Complications of Primary Immunodeficiency Disorders.Immunol Allergy Clin North Am. 2019 Feb;39(1):81-94. doi: 10.1016/j.iac.2018.08.006. Immunol Allergy Clin North Am. 2019. PMID: 30466774 Free PMC article. Review.
-
The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.J Clin Immunol. 2018 Jul;38(5):579-588. doi: 10.1007/s10875-018-0524-9. Epub 2018 Jun 29. J Clin Immunol. 2018. PMID: 29956079 Review.
-
B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.Clin Immunol. 2013 Aug;148(2):258-64. doi: 10.1016/j.clim.2013.05.007. Epub 2013 May 22. Clin Immunol. 2013. PMID: 23773925 Free PMC article.
-
Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.Am J Surg Pathol. 2013 Sep;37(9):1365-72. doi: 10.1097/PAS.0b013e318297427d. Am J Surg Pathol. 2013. PMID: 23887163 Free PMC article.
-
How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients?Curr Gastroenterol Rep. 2012 Jun;14(3):275-81. doi: 10.1007/s11894-012-0258-4. Curr Gastroenterol Rep. 2012. PMID: 22422506 Free PMC article. Review.
References
-
- Holland SM. Chronic Granulomatous Disease. Clin Rev Allergy Immunol. 2009 - PubMed
-
- Malech HL, Hickstein DD. Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol. 2007;14:29–36. - PubMed
-
- Yu G, Hong DK, Dionis KY, Rae J, Heyworth PG, Curnutte JT, Lewis DB. Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease. Clin Immunol. 2008;128:117–126. - PubMed
-
- Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, Marchal CC, Stull ND, Lewis DB, Steele M, Kellner JD, Yu W, Meroueh SO, Nauseef WM, Dinauer MC. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114:3309–3315. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous